Levetiracetam Oral Solution is rapidly absorbed after oral administration, with bioavailability close to 100%, and the blood concentration peaks after 1.3 hours of administration, so it can be diluted with water. Levetiracetam Oral Solution is indicated for the additional treatment of partial seizures in adults, children and infants over one month of age with epilepsy. Levetiracetam is an extremely soluble and highly permeable compound with linear metabolism, small intra- and inter-individual variability, and multiple administrations that do not affect its clearance. Levetiracetam oral solution is rapidly absorbed after oral administration, with an absolute oral bioavailability approaching 100%. Blood concentrations peak 1.3 hours after administration and reach steady-state concentrations after 2 days if administered twice daily. The degree of absorption is independent of the dose, can be diluted with water and is unaffected by food intake. The most common adverse reactions are drowsiness, malaise and dizziness. It is contraindicated in people who are allergic to levetiracetam or who are hypersensitive to pyrrolidone derivatives or any other ingredient. It is recommended that patients should use the drug under the guidance of a physician, avoiding blind self-medication to avoid adverse consequences.